155 related articles for article (PubMed ID: 31257939)
21. Point-of-care screenings at the University of Minnesota: mechanism for civic engagement.
Palombi LC; Bastianelli K; Stratton T
J Am Pharm Assoc (2003); 2014; 54(1):56-62. PubMed ID: 24407741
[TBL] [Abstract][Full Text] [Related]
22. Knowledge, attitudes and beliefs regarding human immunodeficiency virus and in-home testing among a regional sample of student pharmacists.
Tran A; Stewart AL; Covvey JR
Curr Pharm Teach Learn; 2017 Nov; 9(6):980-988. PubMed ID: 29233395
[TBL] [Abstract][Full Text] [Related]
23. Point-of-care C-reactive protein testing to support the management of respiratory tract infections in community pharmacy: A feasibility study.
Sim TF; Chalmers L; Czarniak P; Hughes J; Iacob R; Lee YP; Parsons K; Parsons R; Sunderland B
Res Social Adm Pharm; 2021 Oct; 17(10):1719-1726. PubMed ID: 33500197
[TBL] [Abstract][Full Text] [Related]
24. Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.
Gubbins PO; Klepser ME; Adams AJ; Jacobs DM; Percival KM; Tallman GB
J Public Health Manag Pract; 2017; 23(6):593-600. PubMed ID: 27997479
[TBL] [Abstract][Full Text] [Related]
25. Are community-based pharmacists underused in the care of persons living with HIV? A need for structural and policy changes.
Kibicho J; Pinkerton SD; Owczarzak J; Mkandawire-Valhmu L; Kako PM
J Am Pharm Assoc (2003); 2015; 55(1):19-30. PubMed ID: 25575148
[TBL] [Abstract][Full Text] [Related]
26. Cost analysis of a novel HIV testing strategy in community pharmacies and retail clinics.
Lecher SL; Shrestha RK; Botts LW; Alvarez J; Moore JH; Thomas V; Weidle PJ
J Am Pharm Assoc (2003); 2015; 55(5):488-92. PubMed ID: 26359959
[TBL] [Abstract][Full Text] [Related]
27. Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial.
Radley A; de Bruin M; Inglis SK; Donnan PT; Hapca A; Barclay ST; Fraser A; Dillon JF
Lancet Gastroenterol Hepatol; 2020 Sep; 5(9):809-818. PubMed ID: 32526210
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the impact of influenza and streptococcus point-of-care testing and collaborative practice prescribing in a community pharmacy setting.
Kirby J; Mousa N
J Am Pharm Assoc (2003); 2020; 60(3S):S70-S75. PubMed ID: 32253085
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
30. Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake.
Dowling-McClay K; Mathis SM; Hagemeier N
Explor Res Clin Soc Pharm; 2021 Dec; 4():100088. PubMed ID: 35479840
[TBL] [Abstract][Full Text] [Related]
31. Attitudes toward pharmacy-based HCV/HIV testing among people who use drugs in rural Kentucky.
Duong M; Delcher C; Freeman PR; Young AM; Cooper HLF
J Rural Health; 2022 Jan; 38(1):93-99. PubMed ID: 33666274
[TBL] [Abstract][Full Text] [Related]
32. Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States.
Weber NC; Klepser ME; Akers JM; Klepser DG; Adams AJ
Expert Rev Mol Diagn; 2016; 16(2):253-64. PubMed ID: 26560318
[TBL] [Abstract][Full Text] [Related]
33. A survey of community pharmacists on prevention of HIV and hepatitis B and C: current practice and attitudes in Grampian.
Watson L; Bond C; Gault C
J Public Health Med; 2003 Mar; 25(1):13-8. PubMed ID: 12669912
[TBL] [Abstract][Full Text] [Related]
34. Pharmacist testers in multidisciplinary health care team expand HIV point-of-care testing program.
Sherman EM; Elrod S; Allen D; Eckardt P
J Pharm Pract; 2014 Dec; 27(6):578-81. PubMed ID: 24326407
[TBL] [Abstract][Full Text] [Related]
35. Point-of-Care Screening for a Current Hepatitis C Virus Infection: Influence on Uptake of a Concomitant Offer of HIV Screening.
Geretti AM; Austin H; Villa G; Hungerford D; Smith C; Davies P; Williams J; Beloukas A; Sawicki W; Hopkins M
Sci Rep; 2018 Oct; 8(1):15297. PubMed ID: 30333568
[TBL] [Abstract][Full Text] [Related]
36. Awareness, perceptions, and attitudes toward community pharmacist clinical services: An analysis of data from 2004 and 2018.
Anderson JR; Gonzalez LJ; Sarangarm P; Marshik PL; Hunter TS; Duran NL; Ray GM
J Am Pharm Assoc (2003); 2022; 62(4):1364-1368. PubMed ID: 34996713
[TBL] [Abstract][Full Text] [Related]
37. Pharmacist-provided rapid HIV testing in two community pharmacies.
Darin KM; Klepser ME; Klepser DE; Klepser SA; Reeves A; Young M; Scarsi KK
J Am Pharm Assoc (2003); 2015; 55(1):81-8. PubMed ID: 25415222
[TBL] [Abstract][Full Text] [Related]
38. Pharmacy patron perspectives of community pharmacist administered influenza vaccinations.
Alsabbagh MW; Church D; Wenger L; Papastergiou J; Raman-Wilms L; Schneider E; Waite N
Res Social Adm Pharm; 2019 Feb; 15(2):202-206. PubMed ID: 29724679
[TBL] [Abstract][Full Text] [Related]
39. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
Xi X; Huang Y; Lu Q; Ung COL; Hu H
Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
[TBL] [Abstract][Full Text] [Related]
40. Pharmacist-provided SARS-CoV-2 testing targeting a majority-Hispanic community during the early COVID-19 pandemic: Results of a patient perception survey.
Patel J; Christofferson N; Goodlet KJ
J Am Pharm Assoc (2003); 2022; 62(1):187-193. PubMed ID: 34465524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
